<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01890382</url>
  </required_header>
  <id_info>
    <org_study_id>The Pro Elderly Study</org_study_id>
    <nct_id>NCT01890382</nct_id>
  </id_info>
  <brief_title>Protein Intake and Resistance Training in Aging</brief_title>
  <official_title>Different Protein and Derivatives Supplementation Strategies Combined With Resistance Training in Pre-frail and Frail Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Resistance training combined with protein or amino acids supplementation has been shown to be
      promising for mitigating age-related disabilities and comorbidities. Randomized controlled
      trials supporting this possibility are still scarce. These series of clinical trials aim to
      investigate the chronic effects of different strategies of protein and derivatives
      supplementation in association with resistance training on selected health-related parameters
      in pre-frail and frail elderly.This is a 16-month, double-blind, randomized,
      placebo-controlled, parallel-group clinical trial involving a series of investigations.
      Participants will be divided into nine groups, allowing the assessement of the effects of (1)
      isolated leucine supplementation; (2) protein source (whey vs. soy); (3) combination of whey
      protein and creatine; and (4) sexual dimorphism to the response of protein intake plus
      resistance training (men vs. women). All participants will undergo a supervised, resistance
      training program.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2015</start_date>
  <completion_date type="Actual">August 30, 2017</completion_date>
  <primary_completion_date type="Actual">August 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>lean mass</measure>
    <time_frame>4 months</time_frame>
    <description>assessed by Dual-energy X-ray absorptiometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>muscle function</measure>
    <time_frame>4 months</time_frame>
    <description>assessed by a battery of physical tests</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>bone mass</measure>
    <time_frame>4 months</time_frame>
    <description>assessed by Dual-energy X-ray absorptiometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>insulin sensitivity</measure>
    <time_frame>4 months</time_frame>
    <description>assessed by homeostasis model assessment (HOMA index)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>health related-quality of life</measure>
    <time_frame>4 months</time_frame>
    <description>assessed by Short-Form Health Survey (SF-36) (score range: 0 to 100, higher values mean better quality of life)</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Frail Elderly Syndrome</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>alanine as placebo to leucine (same dosage); corn starch as placebo to protein and/or creatine (same dosage)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>whey protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>soy protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>leucine supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>whey plus creatine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>creatine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Whey protein</intervention_name>
    <description>30 g in total; twice a day (morning and evening)</description>
    <arm_group_label>whey protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>whey plus creatine</intervention_name>
    <description>whey protein combined with creatine (30 g and 6.0 g in total; twice a day, respectively)</description>
    <arm_group_label>whey plus creatine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>leucine supplementation</intervention_name>
    <description>7.5 g/d in total; three times per day</description>
    <arm_group_label>leucine supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>soy protein</intervention_name>
    <description>30 g in total; twice a day</description>
    <arm_group_label>soy protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>creatine</intervention_name>
    <description>6.0 g in total; twice a day</description>
    <arm_group_label>creatine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elderly people

          -  frailty or pre-frailty, according to Fried et al., (2001) criteria.

        Exclusion Criteria:

          -  on exogenous insulin and steroid-based drugs

          -  chronic obstructive pulmonary disease or respiratory failure

          -  use of protein and /or amine-based dietary supplements

          -  on restrictive diets (e.g. calorie or food group restrictions)

          -  on resistance training

          -  untreated cardiovascular, metabolic, or other chronic disease

          -  any musculoskeletal condition precluding resistance training
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruno Gualano, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05508030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>June 26, 2013</study_first_submitted>
  <study_first_submitted_qc>June 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2013</study_first_posted>
  <last_update_submitted>February 12, 2019</last_update_submitted>
  <last_update_submitted_qc>February 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Bruno Gualano</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>resistance exercise</keyword>
  <keyword>protein</keyword>
  <keyword>creatine</keyword>
  <keyword>leucine</keyword>
  <keyword>aging</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

